FGF23 and type 1 diabetes mellitus: Interestingly, autoantibodies targeting FGF23 were found to be responsible for the development of hyperphosphatemic tumoral calcinosis in a patient with no identified genetic etiology and subsequent development of type 1 diabetes (13), resulting in an acquired form of FGF23 resistance due to decreased binding of FGF23 to its receptor.